• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3岁以下心力衰竭儿童的N末端B型利钠肽原评估。

Evaluation of NT-proBNP in children with heart failure younger than 3 years old.

作者信息

Iacob Daniela, Butnariu Angela, Leucuţa Daniel-Corneliu, Samaşca Gabriel, Deleanu Diana, Lupan Iulia

机构信息

"Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca, Department of Pediatrics, IIIrd Pediatric Clinic.

"Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca, Department of Medical Informatics and Biostatistics.

出版信息

Rom J Intern Med. 2017 Jun 1;55(2):69-74. doi: 10.1515/rjim-2017-0002.

DOI:10.1515/rjim-2017-0002
PMID:28118147
Abstract

INTRODUCTION

Heart failure (HF) is characterized by neuroendocrine activation. The cardiac natriuretic hormones, including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), together with their related pro-peptides (proANP and proBNP) represent a group of peptide hormones produced by the heart. A normal NT-proBNP level has a high negative predictive value for heart failure. The use of NT-proBNP testing is helpful in diagnosing acute HF in the emergency care setting, allowing an early and optimal treatment. The purpose of this study is to assess the prognostic value of NT-proBNP in heart failure in children younger than 3 years old and to establish whether it correlates with the NYHA/Ross functional class and left ventricle systolic function.

METHODS

We enrolled 24 consecutive children with HF due to congenital heart diseases and dilated cardiomyopathy. The serum levels of NT-proBNP were measured, all patients underwent echocardiography and left ventricle ejection fraction was calculated.

RESULTS

The highest median value of NT-proBNP was recorded in patients with cyanotic heart diseases (248.0 fmol/mL), p = 0.610. NT-proBNP had a negative correlation with the ejection fraction of the left ventricle: Spearman's rank correlation coefficient was -0.165.

CONCLUSIONS

NT-proBNP levels correlate with the severity of HF in infants and small children younger than 3 years old with heart failure due to congenital heart diseases and dilated cardiomyopathy.

摘要

引言

心力衰竭(HF)的特征是神经内分泌激活。心脏利钠肽激素,包括心房利钠肽(ANP)和脑利钠肽(BNP),以及它们相关的前体肽(proANP和proBNP)代表了一组由心脏产生的肽类激素。正常的NT-proBNP水平对心力衰竭具有较高的阴性预测价值。在急诊环境中使用NT-proBNP检测有助于诊断急性心力衰竭,从而实现早期和最佳治疗。本研究的目的是评估NT-proBNP在3岁以下儿童心力衰竭中的预后价值,并确定其是否与纽约心脏协会/罗斯功能分级和左心室收缩功能相关。

方法

我们连续纳入了24例因先天性心脏病和扩张型心肌病导致心力衰竭的儿童。测量了NT-proBNP的血清水平,所有患者均接受了超声心动图检查并计算了左心室射血分数。

结果

青紫型心脏病患者的NT-proBNP中位数最高(248.0 fmol/mL),p = 0.610。NT-proBNP与左心室射血分数呈负相关:Spearman等级相关系数为-0.165。

结论

NT-proBNP水平与3岁以下因先天性心脏病和扩张型心肌病导致心力衰竭的婴幼儿心力衰竭严重程度相关。

相似文献

1
Evaluation of NT-proBNP in children with heart failure younger than 3 years old.3岁以下心力衰竭儿童的N末端B型利钠肽原评估。
Rom J Intern Med. 2017 Jun 1;55(2):69-74. doi: 10.1515/rjim-2017-0002.
2
[Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].[目前使用的标准及脑钠肽对先天性心脏病患儿充血性心力衰竭的诊断价值]
Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):728-32.
3
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭和射血分数降低患者中 BNP 和 NT-proBNP 的比较。
Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17.
4
[Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].[血浆脑钠肽前体浓度在小儿室间隔缺损合并充血性心力衰竭中的诊断价值]
Zhonghua Er Ke Za Zhi. 2005 Mar;43(3):161-4.
5
Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.B 型利钠肽和氨基末端 B 型利钠肽前体在单心室先天性心脏病幼儿心力衰竭中的标志物作用。
Am J Cardiol. 2012 Mar 15;109(6):866-72. doi: 10.1016/j.amjcard.2011.10.049. Epub 2011 Dec 22.
6
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.比较中段心房利钠肽原与N末端B型利钠肽原在预测慢性心力衰竭患者生存率中的作用
J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. doi: 10.1016/j.jacc.2007.08.012. Epub 2007 Oct 29.
7
Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.小儿心力衰竭新型生物标志物的诊断性能及参考值
Heart. 2016 Oct 15;102(20):1633-9. doi: 10.1136/heartjnl-2016-309460. Epub 2016 May 24.
8
Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.心力衰竭多种表型中的适应性心血管激素
Int J Cardiol. 2015;189:6-11. doi: 10.1016/j.ijcard.2015.03.381. Epub 2015 Mar 27.
9
Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.MR-proANP 和 NT-proBNP 对高龄心力衰竭高危门诊患者的诊断价值:哥本哈根心力衰竭风险研究。
Biomarkers. 2020 May;25(3):248-259. doi: 10.1080/1354750X.2020.1732466. Epub 2020 Mar 4.
10
The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle.左心室射血分数保留的慢性心力衰竭门诊患者的NT-脑钠肽水平
Ter Arkh. 2018 Sep 20;90(9):68-72. doi: 10.26442/terarkh201890968-72.

引用本文的文献

1
NT-pro Brain Natriuretic Peptide in Infants with Single Ventricle Heart Disease in the CHAMP® Multi-site Registry.CHAMP®多中心注册研究中患单心室心脏病婴儿的N末端脑钠肽原
Pediatr Cardiol. 2025 Aug 21. doi: 10.1007/s00246-025-03999-y.
2
N-Terminal Pro-B-Type Natriuretic Peptide as a Marker of Severity of Heart Failure in Children with Congenital Heart Diseases.N 端脑利钠肽前体作为先天性心脏病儿童心力衰竭严重程度的标志物。
Pediatr Cardiol. 2023 Dec;44(8):1716-1720. doi: 10.1007/s00246-023-03259-x. Epub 2023 Aug 11.
3
Point of care with serial N-terminal pro-B-type natriuretic peptide (NT-proBNP) for heart failure in patients with acute decompensation. An invited commentary.
急性失代偿患者心力衰竭的床旁连续检测N末端B型利钠肽原(NT-proBNP)。特邀评论
Contemp Clin Trials Commun. 2022 Jan 25;26:100889. doi: 10.1016/j.conctc.2022.100889. eCollection 2022 Apr.
4
Natural history of propionic acidemia in the Amish population.阿米什人群中丙酸血症的自然病史。
Mol Genet Metab Rep. 2022 Nov 5;33:100936. doi: 10.1016/j.ymgmr.2022.100936. eCollection 2022 Dec.
5
Analysis of Therapeutic Effect of Elderly Patients with Severe Heart Failure Based on LSTM Neural Model.基于 LSTM 神经网络模型的老年重症心力衰竭患者治疗效果分析。
Comput Intell Neurosci. 2022 Aug 28;2022:7250791. doi: 10.1155/2022/7250791. eCollection 2022.
6
Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?N末端B型利钠肽原水平能否作为早产儿左心室射血分数降低的早期生物标志物?
Children (Basel). 2022 Jul 3;9(7):1002. doi: 10.3390/children9071002.
7
Expression of serum microRNA-155 and its clinical importance in patients with heart failure after myocardial infarction.血清微小RNA-155在心肌梗死后心力衰竭患者中的表达及其临床意义
J Int Med Res. 2019 Dec;47(12):6294-6302. doi: 10.1177/0300060519882583. Epub 2019 Nov 10.
8
Saudi Heart Association (SHA) guidelines for the management of heart failure.沙特心脏协会(SHA)心力衰竭管理指南。
J Saudi Heart Assoc. 2019 Oct;31(4):204-253. doi: 10.1016/j.jsha.2019.06.004. Epub 2019 Jun 25.
9
Prognostic value of biomarkers after cardiopulmonary bypass in pediatrics: The prospective PANCAP study.体外循环后生物标志物对儿科的预后价值:前瞻性 PANCAP 研究。
PLoS One. 2019 Jun 17;14(6):e0215690. doi: 10.1371/journal.pone.0215690. eCollection 2019.